国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Erwinia tasmaniensis S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP456999ENB
CSB-EP456999ENB
CSB-BP456999ENB
CSB-MP456999ENB
CSB-EP456999ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP457000ENB
CSB-EP457000ENB
CSB-BP457000ENB
CSB-MP457000ENB
CSB-EP457000ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase (lpxA) CSB-YP457001ENB
CSB-EP457001ENB
CSB-BP457001ENB
CSB-MP457001ENB
CSB-EP457001ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Diaminopimelate epimerase (dapF) CSB-YP457002ENB
CSB-EP457002ENB
CSB-BP457002ENB
CSB-MP457002ENB
CSB-EP457002ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Met repressor (metJ) CSB-YP457003ENB
CSB-EP457003ENB
CSB-BP457003ENB
CSB-MP457003ENB
CSB-EP457003ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Elongation factor P-like protein (ETA_12720) CSB-YP457004ENB
CSB-EP457004ENB
CSB-BP457004ENB
CSB-MP457004ENB
CSB-EP457004ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis UPF0345 protein ETA_25560 (ETA_25560) CSB-YP457005ENB
CSB-EP457005ENB
CSB-BP457005ENB
CSB-MP457005ENB
CSB-EP457005ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis NADH-quinone oxidoreductase subunit C/D (nuoC), partial CSB-YP457006ENB
CSB-EP457006ENB
CSB-BP457006ENB
CSB-MP457006ENB
CSB-EP457006ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD) CSB-YP457007ENB
CSB-EP457007ENB
CSB-BP457007ENB
CSB-MP457007ENB
CSB-EP457007ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Ribosomal RNA small subunit methyltransferase F (rsmF) CSB-YP457008ENB
CSB-EP457008ENB
CSB-BP457008ENB
CSB-MP457008ENB
CSB-EP457008ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP457009ENB
CSB-EP457009ENB
CSB-BP457009ENB
CSB-MP457009ENB
CSB-EP457009ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Potassium-transporting ATPase A chain (kdpA), partial CSB-YP457010ENB
CSB-EP457010ENB
CSB-BP457010ENB
CSB-MP457010ENB
CSB-EP457010ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Glycogen synthase (glgA) CSB-YP457011ENB
CSB-EP457011ENB
CSB-BP457011ENB
CSB-MP457011ENB
CSB-EP457011ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Shikimate kinase 1 (aroK) CSB-YP457012ENB
CSB-EP457012ENB
CSB-BP457012ENB
CSB-MP457012ENB
CSB-EP457012ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Protein tsgA homolog (tsgA), partial CSB-YP457013ENB
CSB-EP457013ENB
CSB-BP457013ENB
CSB-MP457013ENB
CSB-EP457013ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis 30S ribosomal protein S7 (rpsG) CSB-YP457014ENB
CSB-EP457014ENB
CSB-BP457014ENB
CSB-MP457014ENB
CSB-EP457014ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis 50S ribosomal protein L22 (rplV) CSB-YP457015ENB
CSB-EP457015ENB
CSB-BP457015ENB
CSB-MP457015ENB
CSB-EP457015ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis 30S ribosomal protein S11 (rpsK) CSB-YP457016ENB
CSB-EP457016ENB
CSB-BP457016ENB
CSB-MP457016ENB
CSB-EP457016ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Tryptophan synthase alpha chain (trpA) CSB-YP457017ENB
CSB-EP457017ENB
CSB-BP457017ENB
CSB-MP457017ENB
CSB-EP457017ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Pyrroloquinoline-quinone synthase (pqqC) CSB-YP457018ENB
CSB-EP457018ENB
CSB-BP457018ENB
CSB-MP457018ENB
CSB-EP457018ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>